trial · primary record
COL-5671-PRO
Plaque Psoriasis
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 100 |
| Primary completion | 2027-12-31 |
| Primary endpoint | Reduction of 75% in PASI score relative to baseline (PASI75) at Week 12 |
| Registry ID | NCT07914231 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:33.515Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07914231
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.